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We studied the effect of IL-4 on the proliferation of 
cultured normal human keratinocytes. Keratinocyte 
proliferation was stimulated by IL-4 and inhibited by 
anti-IL-4 antibody in a concentration-dependent 
manner. Anti-IL-6 antibody did not inhibit normal 
human keratinocyte proliferation, suggesting that 
the IL-4 could directly induce proliferation of these 
cells. IL-4 significantly induced cell cycle Go/GJ to S 
phase progression. The keratinocyte proliferation by 
IL-4 was nlediated through one of the growth control 
genes, c-myc protooncogene. The expression of c-myc 
mRNA was significantly increased after IL-4 treat-
ment of the keratinocytes, suggesting that c-",yc 
plays a key role in the control of proliferation. The 
signal transduction pathways induced by IL-4 in the 
I L- 4 is aT-cell-derived cytokine that displays pl eiotropic biologic effects not on ly on many hematopoietic cells, including B cells. T cells, mast cell s, m 3crophages. and basophils (Spits, 1992), but also on nonhe matopoietic cells (Tushinski el nl, 1991; Fertin et nl, 1991) . C-III)'C appears to 
playa key role in cellular proliferation, and expression of C-III}'C is 
tightly associated with proliferation in nontransformed cell s (Lus-
cher and Eisenman, 1990; Spencer and Groudjne, 1991). Indeed . 
C-IIIJ'C actjvation may comlnit the G I to S phase of cell division 
(Ei lers el nl, 1991) . Deregu lation of C-IIII'C, a protooncogene and an 
early response gene to mitogen o r growth f.1ctor stimul ation, is 
characteristic of 1113ny tumor cells, suggesting that its product plays 
a major role in growth control. 
LL-4 upregulates LL-6 production in endothelial cells, skin fibro-
blast cells, and keratinocytes (Howells ef nl, 1991; Feghali el nl, 
1992; D erocq el nl, 1994). The observation that IL-6 stimulates the 
proliferation of normal human ke ratinocytes in culture prompted us 
to inves tigate the ro le of IL-4 in the process. In the current study, 
we analyzed the effect oflL-4 on the proliferation of normal human 
keratinocytes by examining eHlthymidine in corporation , the ex-
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keratinocytes were studied with inhibitors of signal 
transduction. Genistein, a tyrosine kinase inhibitor, 
suppressed the level of the induced c-myc mRNA 
expression, but H7, a serine/threonine kinase inhibi-
tor, and okadaic acid, a protein phosphatase 1 and 2A 
inhibitor, did not block the induced c-ttlyc gene ex-
pression. Taken together, these results suggest that 
IL-4 stinlulates the proliferation of keratinocytes jll 
I,ityo by promoting a transition from Go/G t to S phase 
of the cell cycle. Induction of c-IIIyc after IL-4 treat-
ment could indicate an important role for C-III)'C in 
the proliferation of keratinocytes. Our observations 
also suggest that tyrosine kinases may be involved in 
IL-4-induced proliferation. KeJI lVords: cell cycle/tYI'osille 
killase. ] [livest Dev",atol 107:367-372, 1996 
pression of cell cycle-regulating nuclear f.1cto rs, such as C- III ),C, and 
the cell cycle. As yet, there is little direct evidence for the 
i.nvolvement of a specific tyrosine kinase in response to lL-4 
signaling through the IL-4 receptor (IL-4R) . and much less is 
known about the tyrosine kinase casca de evoked by TL-4 . We 
therefore sought to determine the signaling pathway triggered by 
IL-4 in keratinocytes. QUI' results provide evidence that IL-4 
activates a tyrosine kinase cascade that m ediates LL-4-indu ced cell 
growth and is an important positive regulator of the cell cycle in 
keratinocytes. These resu lts suggest that lL-4, like IL-6, may playa 
potentially important ro le in the immWlc and inRammatory re-
sponses of the skin, stimulating proliferation of both epidermal cells 
and lymphoid cells. 
MATERJALS AND METHODS 
Reagents Keratillocyte basa l medium (KBM) and keratinocyte growth 
mediull1 (KGM) supplcmentcd with epidermal growth filctor and bovine 
pitui ta ry extracts were purchased fi'om C lonetics Corp. (San Dicgo. CA) . 
rJH]thymidine (83 C i/ mmol) and /a-J2 PJdCTP (3000 C i/ mll1o l) were 
obtained from Amersham Corp. (Arlington Heights. IL) . R ecombinant 
human lL-4 and anti-Itnll\a.n lL-6 an tibody were the product of GetlzYllIc 
(Boston. MA) . W c also used recombinant IL-4 prepared &om Esrlll'richin ro/i 
BL21 (ADE3) carrying rJlC pET-3b/ IL-4 plasmid by induction with I mM 
isopropyl-{3-D-rJliogaJactopyranosidc, carboxymctllyl-ceUulose colul11ll 
(1 .. 5 X IO cm ; Sigma C hemical C o. , St. Louis, MO). and capillary 
electrophoresis (PI ACE System 2000; Beckman, Fullerton, CAl . The 
recombinant IL-4 showed " biologic activity with a calculated specifi c 
activity of J X 10" U / mg in B-ccll proliferation assay. Anti-human IL-4 
antibod)', transforming b'rowth factor-a (TGF-a ), okadaic acid. and dispase 
(ncutral protease grade II) wcre purchased frolll Boehringer MannheiJ1l 
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(tndianapolis, IN) , and protein kinase inhibitors, H7 and genistein, were 
from GmCO (Grand l sland, NY) . RNA zol B was obtained from Biotecx 
Laboratories Inc. (Houston, TX). Insu lin-like growth factor-I (IGF-I) was a 
gi ft fi'om Y.1. Lee (Korea Institute of Science and TeclUlology, Taejon, 
Korea). The cD NA for glycera ldeh yde-3-phosphate dehydrogenase was 
purchased from the Amcrican Type Culture Collection (H ... ockville, MD). 
The c-/llye hybridization probe (1.4 kb, third cxon) was obtained from 
Ollcor Inc. (Gaithersburg, MO), and actinomycin 0, cycloheximide, and 
propidi um iodide were from Sigma. 
Culturc of Keratinocytes Human kerati nocytcs were obtained from 
fi'esh foreskin biopsies of adu lt donors and cultured as described previously 
(Saunders andJetten, 1994) . Briefly, the foreskin specimens were cut in to 1-
X 5-nUll pieces and incubated in 0.1% di spase so lu tion for 90 min at 37°C. 
The epidermal layer was detached (rom the dermis with sharp forceps and 
incubated in solu tion A (30 mM HEPES, pH 7.4, 10 mM glucose, 132 mM 
NaC I, "I mM Na2 1-1PO", and 3 mM KCI) supplemented with 0.05% trypsin 
and 0.53 mM EDTA for ')0 min at 37°C. Keratinocytes separated from the 
trypsinized epidermis were cu.Itured in KGM. The cells were grown to 
80-90'10 confluence, trypsinized, and subcultured in 10-cm dishes (Costar, 
Cambridge, MA). T he fourth to sixth passage keratinocytes were used for 
the cXperil11 cnts. 
Proliferation Assay Proliferative growth was assessed either by [' H) thy-
midine in corporation or by ceU counts as previously described (Turka el "I, 
1990) . Kerntinocytes grown in KGM were plated in 96- o r 24-weU 
flat-bottomed m icroplates (Costar, Cambridge, MA) at a concentration of 
'1 X '10' ce ll s per well in a final volume of200 /LI or 1ml. respectively, and 
cu lt.ured for 24-48 h . To arrest the keratinocyte growth in Go/G , phase, 
cultures were washed rwice with solution A and incubated in KBM for 18 h. 
I L-4 was theD added at the indicated concentrations, and the cells were 
incubated for 48 h with [3H]thymidine (0.5 /LCi/well) added for the last 6 h . 
After the ceUs were harvested with trypsin, the amount of eH]thymidine 
uptake was counted by liquid scintilla tion spectrometry (Beckman 
LS6000A), or the number of viable cells was cOllnted with a hemocytometer 
after trypan blue exclusion. Results were calcu lated as the means ::': SEM of 
triplicate cultures. 
Cell Cycle Analysis Keratinocytes grown in KGM were plated on 
1 O-cm di shes at a concentration of 1 X 10" cell s per di sh and maintained for 
24-48 h. Cells were treated with 1 ng IL-4 per ml after starvation in KBM 
for 18 h . T he ceLIs were washed with phosphate-buffered saline, trypsinized, 
pclleted by centrifuga tion at 800 rpm for 5 min, and resuspended in 1 ml of 
phosphate-buffered sa line at the indicated times. The cell s were inullediately 
fixed by the addition of 3 ml of cold 95% ethanol at 4°C for at least 12 h 
fo llowed by centrifugation at 1500 rpm for 10 min. The supernatant was 
carefull y removed, and 1 ml of PI so lution (3.8 mM sodium citrate, 1 mg 
RNase A per 1111, 50 f.Lg propidium iodide per 1111) was addcd to each peUet. 
The cells were gently mLxed and incubated at room temperature in the dark 
for at least 30 min , and the number of cells was measured. Cells (1 X '10") 
were subjected to FACScan. The percentages of ceUs in each phase of ce ll 
cycle were ca lculated by using Cellfit software (Becton Dickinson, San Jose , 
CAl· 
Northern Blot Analysis Keratinocytes grown in KGM were plated on 
10-cm di shes at a concentration of 1 X 10" ce lls per dish and cu ltured for 
24 -48 h . Keratinocytes were treated with 1 ng IL-4 per 1111 after incubation 
in ({BM for 1. 8 h and washed with co ld phosphate-buffered saline at the 
indicated time interva ls. Northern blot anal ysis and extraction of total 
ceUular RNA were performed as described previously, with modifications 
(Ha 0/ (/1, '1992). In brief, the total cellular RNA was prepared with RNAzol 
B under conditions recommended by the manufacturer. Approximately 30 
/Lg of total RNA were electrophoresed through 1. % agarose-formaldehyde 
gel, transferred to Gcnescreen PillS nylon membrane (DuPont-NEN, Bos-
ton, MA), and vacu um-dried at 80°C for 2 h . The membranes were then 
hybridized to random primer-labeled cD NA probes in 50% form,"nide, 
"lO'X, dextran sulfate, 7% sodium dodecy l sul fate, 0.25 M NaHPO,., pH 7.2, 
0.25 M NaCI , 1 111M ethylenediamine tetraacetic acid, and 100 /Lg 
denatured sa lmon sperm DNA per ml at 42°C for 18 h . The membranes 
were washed with 1 X sodium citrate/sodium chloride bulfer and 0.2% 
sodiuJTI dodecyl su lfate at room temperature for 15 min, 0.5 X sodium 
citratclsodium chloride bulfer ,md 0. 2% sodium dodecyl sulfate at room 
tempcrature for 1.5 min, and 0.25 X sod ium citrate/sodium ch loride buffer 
and 0.2% sodium dodecyl sulfate at 60°C for 15 min. Autoradiograms were 
prepared using Kodak XAJ~-5 tjlm with intcnsifying screcns at - 80°C for 
24-48 h. The same membranes were h ybridized to 32P-l.abelcd glycera lde-
hyde-3-phosphatc dehydrogenase cDNA to verify equal loading ofKNA. 
Reverse Transcriptase-Polymerase Chain Reaction (PCR) I-Iuman 
keratinocytes incubated for 18 h in ICBM were treated with 2.5 ng IL-4 per 
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ml for the indicated times . Total cellular I~A was isolated as prev iously 
described and converted to cDNA under the following conditions: the 
I~A (1 f.Lg) was solubilized at 65°C for '15 min and incubated for 1 h at 
37°C with 19 /LI of reverse transcription mixture containing 1 X reverse 
transcriptase bufFer (GIBCO BRL, Gaithersburg, MD) , lmM deoxynucleo-
side triphosphate, 0.25 /Lg of o ligo deoxythymidylic ce llulose (Promega 
Biotec), 5 mM dithiothreitol, and 200 U of murine moloney leukemia virus 
reverse transcriptase (GIDCO BRL). PCR. was performed w ith 5 /LI of 
first-strand eDNA on a DNA thermal cycler (Ericomp IJl C, San Diego, CAl 
in 50 /LI containing 1 X PCK bulfer (50 111M KCI, '10 111M Tris(hydro,,"J'-
methyl)-ammom"thane, pH 9.0, 5 mM MgCI 2 , 0.01% gelatin, 0.1% Triton 
XlOO), 0.4 f.LM of each primer, and 2.5 U of Taq polymerase (Korea 
Biotech, Taejon , Korea) for 40 cycles. Each PCR. cycle consisted of 
annea ling at 55°C for 30 s, extension at 72°C for 1 mil1, and denaturation 
at 94°C for 30 s. The amplified PCR products with the expected sizes were 
electrophoresed o n a 1.5"It, agarose gel (319 bp for IL-4, 617 bp for IL-6, 548 
bp for /3-actin). The sequences of the o ligonucleotides are as fo llows: for 
IL-4 , sense oligonucleotide, 5'-GTGCGATATCACCTTACAGG-3'; anti-
sense o ligoD ucleotide, 5 '-ACGTACTCTGGTTGGCTTCC-3'; for IL-6, 
SC11SC oligonucleotide, 5' -ATGAACTCCTTCTCCACAAGC-3'; antisense 
oligonucleotide,S' -GAAGAGCCCTCAGGCTGGACTG-3 '; for /3-actin 
(Butch c{ (/1 , 1993), sense o ligonucleotide, 5' -GTGGGGCGCCCCAG-
GCACCA-3'; antisense oligonucleotide, 5'-CTCCTTAATGTCACG-
CACGA TTTC-3' . 
Statistical Analysis Statistical analysis was carried out using the Stu-
dent's t test, and all values are represented as the mean ::': SEM . 
RESULTS 
IL-4 Stimulates Proliferation of Cultured Keratinocytes 
To evalu ate the possible effect oflL-4 on keratinocyte prolife ration, 
we treated cells with 0, 0.01, 0.1, I, or 10 ng IL-4 per ml for 48 h 
in IG3M. As shown in Fig 1d, IL-4 significantly increased eH]thy-
midille uptake by keratinocytes in a concentration-dependent man-
ner (m3)";l11al at 1 0 ng per 1111), whereas, as with the ceU growth rate 
shown in Fig 1e, we observed a plateau or slight decrease at 
concentrations of more than 1 ng per ml in seven of 15 independent 
experiments (data not shown). To eliminate possible contamination 
of the recombinant IL-4 with other mitogens, we a lso tested the 
recombinant IL-4 before use in the proliferation assay. Heating IL-4 
to 90°C for 30 min or 70°C for 1 h abrogated its proliferative 
activity on keratinocytes (data not sh own) . The property oflL-4 to 
stimulate keratinocyte proliferation was confirmed in experiments 
determining the number of cells, with trypan blue excl u sion to 
ensure viability, after addition of graded amounts of IL-4. The 
growth- stimulatory effect of fL-4 also increased in a concentration-
depende nt manner and reached a peak at 1 ng per ml (Fig 1e). A 
comparison of the keratinocyte proliferation induced by !L-4 and 
potent keratinocyte mitogens such as IGF-l and TGF-a showed a 
significant increase, although to a somewhat Jesser extent, in 
keratinocyte proliferation with IL-4 treatment. As shown in Fig 1 
(a,b,d), IL-4, IGF-I, and TGF- a increased [3H]thymidine uptake by 
approximately 2.5-, 3 .1-, and 4-fo ld, respectively. 
IL-4 Stimulates Keratinocyte Proliferation Distinct from 
That Induced by IL-6 We exam ined the possibility that the 
IL-4 effect on the proliferation of human keratinocytes cou ld be 
mediated by induction of IL-6. A proliferation assay was performed 
in the presence of neutralizing antibody to determine whether or 
not the IL-4 effect was direct. As shown in Fig 2a, we did not 
detect changes in growth in response to anti-IL-6 antibody (0-10 
J.Lg per ml) in IL-4-treated keratillocytes, but, when the cells were 
treated with IL-4 (2.5 ng p e r m.l) combined with the indicated 
concentrations of anti-IL-4 antibody, antibody concentration-de-
pendent inhibition of keratinocyte growth was observed (> 60% 
growth inhibition at anti-IL-4 antibody concentration of 1 0 J.Lg p er 
ml). To further investigate whether IL-4 could increase the level of 
IL-6 mRNA, we performed reverse transcriptase-PCR to rule out 
the influence of lL-4 on IL-6 production in normal human kerati-
nocytes. We did not detect a significant increase in the levels of 
IL-6 message and did not find a detectable level of IL-4 message 
after IL-4 treatment (Fig 2b) . Taken together, the data indicate tllat 
the IL-4-illduced proliferation in human keratinocytes occurs 
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Figut'e 1. IL-4 is mitogenic in human keratino-
cytes . (n-d) Keratinocytes were seeded in 24-well 
plates at 1 X 10· cell pCI' well. Cells illc ll bated for 18 h 
in KBM were treated with IL-~. IGF- I, and TGF-cx 
(posirive con trol), or IFN-y (negative o ntrol) ar th e 
indic;l rcd concentrations. After 42 h . the cu ltu res \"ere 
pulsed with [3HJthYlllidinc for 6 h. (e) Human kcrati-
nocytes were seeded in 24-well plate. at 2 X 10· ce ll s 
per wel l. Kerarinocytes incubated for ·18 h in KDM were 
treated with IL-4 at the indicated con centrations. The 
cell number, determined b), trypa n b.lue excl usion. was 
counted with a hemocytometer after 48 h. Data repre-
sent the m eans of two separate experiments = SEM 
carried out in duplicate (cell counting) alld the m eans = 
SEM of two separate expcriments carried o ut in tripli-
cate (I) H.lthymidine uptake). ' . p < 0.05 tlerSIIS control: 
**, p < 0.01 IIef SIlS con tro l. 
through the effect of IL-4 alone, not IL-6 production induced by 
IL-4, suggesting the existence of an IL-4-mediated paracrine 
growth loop ill human keratinocytes. 
IL-4 Promotes Cell Cycle from GO/G1 to S Phase Concen-
tration-dependent stimulation of the growth of nonnal human 
keratinocytes by IL-4 in a 48-h proliferation assay and the sequen-
tial expression of c-//Iye following exposure of cells to IL-4 (see 
below, Fig 4a) llldicate IL-4 is a positive regu lator of cell cycle 
progression and growth of these cells. To directly assess th e effect 
ofIL-4 on cell cycle progression, keratinocytes were precultu red in 
basal mediul11 for 18 h, then treated with 1 ng IL-4 per 1111 and 
incubated for the indicated times (0, 12, 24, o r 48 h) before DNA 














markedly increased S-phase population (compared to the ulltreated 
control cultures) was observed w hen the cells werc treated with 
IL-4, w hile the Go/G , phase of population was cOITespondingly 
decreased. T hese results indicate that 11.-4 activation was respon-
sible for progression fro l11 G,/G 1 to S phase. 
c-myc Gene Transcription Is Induced by IL-4 To better 
understand the mechanism by w hich IL-4 stimulated keratinocyte 
growth and ce ll cycle progression , we investigated thc level of 
transcripts for several factors such as c-fi>s, C-)III1. and c-/II)'c, which 
arc known to regulate cell cycle progression from Go/G 1 to S 
phase. Expression of C- III)'( increased in the treated cell s in a 
time-dependent rnanner after treatment with lL-4 at a concentra-
tion ofl ng per ml (Fig 4a), as early as 30 l11in ;lfte[ stimu lation, and 
+ + + 
6 12 24 
I}- Actin 
Vi 
- - - -- - IL- 6 
F ig ure 2. IL-4 dit'ectly stimulates kerati-
noeyte proliferation. (fl) Effect of mAbs to 
IL-4 and IL-6 all IL-4-induced proliferation . 
Cells were treated with lL-4 (2.5 IIg pcr ml) that 
'vas prcill cubatcd in the presence of va rious 
concentratio ll s of IL-4 alld lL-6 mAbs (0. 2. or 
10 ILg pCI' ml) for I h. Bnr" represent meall 
percentages of[-' HJ thymid.ine uptake ind uced by 
I L-4 and the means = SEM of three separate 
experimellts carried out in tripli cate. (b) Effect of 
IL-4 on IL-4 and IL-6 m R.NA express ion. Cells 
incubated fo r 18 h ill KBM were culturcd in the 
prescnce of IL-4 (2.5 ng per ml) for lhc indica ted 
times. Total cell ul ar R.NA was isolated. and 
reverse tra.nscriptase-PC R W :IS carried out for 40 
cycles as described ill Mnl,.";"ls nlld lIJlt'llrads. 
' . P < 0.05 IIersll .' control. 
20 
IL- 4 
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Figure 3. IL-4 triggers promotion of Go/G, to S phase. Cells incubated for 18 h in ICBM w ere treated w ith or wit.hout I L-4 (1 ng per ml) and tllrther 
cultured for 0 (a), 12 (I,) , 24 (c), or 48 h (eI). Cells were h""vested at the indica ted times, fixed with ethanol , incubated with PI solu tion, and analyzed by Aow 
cytometry. Percentages of ce ll s in G,,1G I and S phases of the cell cycle are indicated in each pan el. 
maximum expression of C-/JI)'C was observed approximately 6 h 
after IL-4 treatment (data not shown) . Although there was no 
significant difie rence in C- lllyC ml't.NA expression throughout the 
time course (1-24 h) , a decline in C- III)'C mRNA expression was 
o bserved after 24 h treatment (Fig 4a) . To determine how the 
indu ction of C-I/I)'C mRNA expression was regulated, keratinocytes 
w ere trea ted either with IL-4 alone or with IL-4 together with 
actinomycin D or cycloheximide. As shown in Fig 41J , the treat-
m ent w ith actinomycin D (5 /-Lg per ml) completely eliminated 
detectabl e c-m)'c mRNA in both control and IL-4-treated cultures . 
In addition, when the cells w ere treated with cycloheximide (20 /-Lg 
per 1111), IL-4-induced upregulation of C-I/I)'C mRNA expression 
was slightly decreased . These observations suggested not only that 
IL-4 regnlation of C-/1"I)'C expression occurs at the transcriptional or 
post-transcriptional levels, but that this induction requires, a t least 
partially, the participation of de /1.0 /10 prote in synthesis. 
Genistein Inhibits the Induction of c-",yc rnRNA and Pro-
liferation Induced by IL-4 Because IL-4 is known to induce 
tyrosine phosphorylation, we ana.lyzed th e possible involvement of 
tyrosi.ne kinases in C-III)'C ml'l-..NA expression and cell prolifera tion. 
After treatment of cultured keratinocytes with IL-4 (5 ng per ml) 
and genistein (15 /-LM) , we observed a marked reduc tion in C-III)'C 
ml'l-..NA expression (Fig Sa) . In contrast, H7 (20 /-LM), a serine/ 
threonine 'kinase inhibitor, did no t influence expression of C-III)'C 
mRNA in the presence ofIL-4 (5 ng per 1111) . Okadaic acid (50 ng 
per ml), however, slightly in creased C-III)'C mRNA induction by 
IL-4 . T hese findings suggest that IL-4-induced C-III)'C mRNA 
expression is m ediated by tyrosine kinase. In addition, as demon-
strated in Fig Sa, neither basal nor lL-4-induced levels of C-III}'C 
mI'l-..NA expression were altered by H7 and okadaic acid treatment, 
but a comparison of th e C- III)'C mRNA levels in control (Fig Sa , lall e 
1) and genistein-treated cells (Fig Sa , l alle 5) revea ls that genistein 
do wnregulated the basa l levels of C-III)'C mRNA, suggesting that the 
Figure 4. IL-4 induces C-IIIYC mRNA a) 
expression. (a) Effect of IL-4 on C-III)'C 
mRNA expression. Keratinocytcs were 
cultured for 18 h i.l1 ICBM prior to stimula-
tion with 1L-4 (1 ng per ml) for the indi-
cated times (0 , 1 , 6, or 24 h). (I,) Effect of 
cycloheximide and actinomycin 0 011 the 
induction of C-I/I)'C mRNA by IL-4. T he 
cells were pre-treated for 30 min with 
cycloheximide (C HX, 20 ILg per ml) or 
actinomycin 0 (ACD, 5 ILg per ml) prior to 
stimulation with IL-4 (5 ng pcr ml) for "[ h. 
O dd /lllIlIl,ered lallc, represent the unstimu-
hlted cells. and clle" tllllubcrcd 1(llIes represent 
the lL-4-stimulatcd cell s. Total RNA (ap-
proximately 30 /.Lg/lane) was assayed by 
nordlcm blot for hybridization to C-I/I)'C 
(2 .2 kb) and glyceraldehyde-3-phosphate 
dehydrogenase (1.3 kh) cDNA prohes . 
IL- 4 
hours 
+ + + 
o 6 24 
constitutive C-III)'C mRN A expression in cultured keratill ocytes 
might be specifically regulated by tyrosine kinase . 
To assess whether inhibition of C-1I1}'C by genistein was re fl ected 
in cell proliferation, cultured keratinocytes w ere treated with 5 n g 
lL-4 per m1 in the presence of genistein ranging fi·om 10 - 8 to 10 - 4 
M. As shown in Fig 51J, ['H]thymidine incorporation induced b y 
IL-4 was blocked in a concentration-dependent m anner by 
genistein. T aken together, these data suggest that genistein is abl e 
to inhibit lL-4-iJJduced C-111)'C mRNA exp ression and cell prolifer-
ation in human keratinocytes. 
DISCUSSION 
In addition to the possible involvement of tyrosine kinases in 
IL-4-induced proliferation , w e show that IL-4 induces the growth 
of normal human keratinocytes, C-I/I)'C gene expression, and Go/G, 
to S phase progression . Compared with potent keratinocyte mito-
gens such as JGF-I and TGF- a , IL-4 showed a less profound 
growth-promoting effect, but IL-4-induced prolifera tion was con-
sistently observed from all donors tested. The IL-4-induced pro-
liferation was not m ediated by producti on of IL-6, w hich w as 
shown to indu ce the proliferation of keratinocytes (Fig 2a,b). 
Recently, Derocq el al (1 994) reported th 'lt TL-4 stimu lates IL-6 
production in keratinocytes , but we did not de tect IL-4-mediated 
IL-6 productio n. This discrepancy of IL-4 responsiveness in kera-
tinocytes may be explained by the difl:e rence in culture conditions, 
especially in the culture medium. 
R ecent studies demonstrated that C- III)'C gene expression is 
necessary for proliferation of the murine keratinocytcs (Pietenpol el 
ai, 1990) and other mammalian celJs (Heikkila eI ai, :1987; Goodrich 
e/ ai , J 991). Our studies clearly demonstrate that IL-4 induced 
C-lIf)'C ml'l-..NA expression in association with prolife ration ill /liM), in 
agreement with previous reports o n the rol e of C-lI1 l'C in Go-G I celJ 
cycle progression. The c-Jos protooncogene has been shown to be 
b) 
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Figure 5. IL-4 induces c-IIIl'c .nRNA expression and cell proliferation in a tyrosine kinase-dependent manner. ({/J Inhibition of c-II/)'r mRNA 
induction by genistein, a ty ros ine kinase inhibitor . 1-lull1an keratinocytcs grown ill Kl3M for 18 h were incubated in the presence of 20 J.LM 1-1 7. 15 J.LM 
genjstein (Gen), or 50 ng obd"ic acid (OA) per ml tor 30 min prior to stimulation with either mediull1 alone or medjum with I L-4 (5 ng per ml) fori h. 
Odd 1IIIIIIbered In//l',. show the unstimu lated cell s, and ,' /Jell IIl1l1/bowl Inlles show IL-4-sti1l1u lated cell s. Even loading and integrity of R.NA per lan e was 
confLTmed by ultra violet visuali zation of ethid iu1l1-bromide stain;ng :lI1d hybridi zation with .'2P-labcled glycera ldehyde-3-phosphate dehydrogenase eDN A 
(Io/lle,. p,,"e1). Total cellular RNA was isolated and exa mined by northern blot ana lysis as described in /III"'eri"ls "lid Merltods. (bJ Suppression of the 
fL-4-ind uced proliferat ive response by gelliste in. T he cells were incubated as in panel A and tre:,ted with 5 ng I L-4 per m l in the presence or abse ll ce of 
genistein from 10- " to 10-" M. Each poin t indicates the means :t SEM of two separate experiments carried out in triplica te, and the results arc presellted 
as the percentages or IJ I-Ilthymidil1l! uptake induced by IL-4 alone. *, p < 0.05 IIC", " S con tro l; " , p < 0 .0 :1 lIe ,.,."s control. 
highly expressed in human e pidermal cells (Basset-Seguin el aI, 
1990). In murine keratinocytes, it has been suggested th at c-ji,s 
might be involved in the indu ction of corn ifi cation, a c haracteristic 
featu re of squamou s cell differentiation (Fisher l'1 nl , 1991; Basset-
Seguin e/ aI, 1994) . In our experimen ts , expression of c-fos was no t 
d e tected even after lo nger exposure . w hereas c-J un was more 
readily detecta bl e without induction throughout IL-4 treatment for 
2 h (data not shown). It seems tha t differential regu lation of C~f()s 
and c-Jun gene expression m:1y occur in IL-4-trented human 
keratin ocytes, raising the possibility that C-III)'C gene expressio n m ay 
be the primary regul ator of kerati nocyte g rowth . We cann ot 
exclude other possibilities, howeve r, such as the ;nvo lvement of 
cyclin-dependent tyrosine kinases and cycli.n 0 1 . 
Previo us studies showed that the Hctivation of tyros in e kjnases 
p lays a pivotal ro le in m ediating signa l tra nsd uction th roug h a 
variety of cytokille receptors. R.ecen tJ y it was demonstrated tha t 
lL- 4 induces tyrosin e phosphorylation of several substrates in 
various cells (Keegan el aI, 1994) and is a unique growth-stimulat-
ing cytokin e in tha t it does not emp loy cellular p21""-guanosin e 
triphosphate complexes Or mitogen-activated protein kinase (Satoh 
ct. aI, 1991 ; W elh,nn el nl, 1992) . Despite exten siv e efforts over the 
last few years, signaJ transduction induced by IL- 4 re main s poorly 
understood and somewhat con troversial (Miz uguchi el nl, 1986; 
Cha ikin el nl, 1990; Finney el nl, 1990). I t is tempting to sp ecu late 
that the tyrosine kinases may be involved in prolife ration and C- III)'C 
g ene expressio n in ke l'atil1oc ytes in response to IL-4. A lthough 
genistein, a tyros in e kinase inhibi tor, nearly completely p reven ted 
IL-4-indu ced C-IIIJ'f mRNA express io n as well as g rowth of the 
c ul tured keratinocytes, tbe increase in C-III J'C ge ne express io n by 
IL-4 was not reduced b y e ither H7, a SerlTh.r kinase inhibitor, o r 
okadaic acid, a prote in phosphatase inhibitor (Fig Sa). T hus. our 
stud ies provide evide n ce that activatio n of the tyros ine kinase 
path way in ke ra tinocytes can lead to the gene ration of sig na ls for 
indu ction of C-III )'C mR.NA and even tually ca use the enhancem e n t 
of prolifera tion . Neve r the less, we cann ot rule o u t the possibility 
that other sign al pathways are in vo lved in transduc ing proliferation-
r e lated signals by IL-4 in keratin ocytes. 
O ur studies provide evidence tha t the proliferation of Iltnnan 
keratinocytes indu ced by IL-4 ma y re late in a direc t o r indirect 
manner to C-tII)'c gene expression. M o reover, it seem s reasonable to 
specu late that the putative tyros ine ki nase ac tivation m ay lead to 
g rowth stimulatio n induced b y lL-4, poss ibly through C-IIlyC gene 
expressio n , but it sti ll re mains to be e luc idated w he the r human 
keratinocytes utilize the same or diftc l'en t signal tran sduction 
patJl\¥ays in th e process of pro liferation and differe ntiation in 
respon se to difre rent stimuli . 
IIVI' IlulI/N Dr. Pc'll'r D. Burml/ 's, D;";S;(111 of Chl1icn l nlld DCllrloplllflll nl 
1""1111 11( 11).U, U II;" C/"s il)' oj" A lnbmll" nl Binllill.~/ItI/II , Jor Itc/pfi ll disfllS.<iolls nlld 
rril icnl !"I'" ielll I~rllt r 1I/""l1sail"; " lid Dr. HIICIIS Sik C lmi, Mill C IIIIII Gil, nl ld Yoo 
I\li C lIO; J;,r III fl""$C";I1' prepflfnliall. T his work· lI'fl." pnl1inll)' sHpl'ol1ed b), Graws 
NS "/ JJO tI/IIf E720/o .Iimll III/" M illisll'Y '!f Sricllcc nlld Tee/IIIIl/I).!!)' tl lld KOI"I'n 
Re .... earch IIlS/illlil' (~r Biosril'1I{l' n"d Bi()/ccll1l% g ), . Dr. S. 1\'1. Byull lI' ns partinlly 
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R eplI"'ic "fK" .... ". 
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